Assessment value of interleukin‐6, procalcitonin, and C‐reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: A prospective study
Cancer Medicine · 2024
DOI: 10.1002/cam4.7307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Haifeng Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Central Hospital of Xiangtan, Xiangtan, China. Hauptthemen laut MEDLINE: C-Reactive Protein, Interleukin-6, Procalcitonin, Anti-Bacterial Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: medical research project plan of Xiangtan City in 2021.
Abstract (Originalsprache)
Background
This study aims to investigate the early kinetics of interleukin 6 (IL‐6), procalcitonin (PCT), and C‐reactive protein (CRP) on initial antibiotic efficacy in hematological disorder patients with febrile neutropenia (FN).
Methods
A total of 40 patients with 43 episodes of FN were enrolled and divided into initial antibiotic effective group (IAE group, n = 24) and initial antibiotic ineffective group (IAI group, n = 19). The levels of IL‐6, PCT, and CRP before antibacterial treatment (T0), and 12 h (T1), 24 h (T2), 48 h (T3), and 72 h (T4) post‐antibacterial treatment were determined, respectively. Furthermore, the receiver operating characteristic curve (ROC) analysis was performed to evaluate the clinical value of indicators.
Results
In IAE group, the IL‐6 levels gradually decreased from T0 to T4, and the CRP levels significantly decreased at 48 to 72 h, whereas both IL‐6 and CRP remained at high levels in the IAI group. The PCT levels in both groups increased at the early stage of anti‐infection (T1–T2) and reached to peak at T1–T2 in effective group. ROC curve analysis identified IL‐6 as a predictive biomarker for initial antibiotic efficacy at 12, 48, and 72 h after treatment, with the AUC of 0.698, 0.744, and 0.821, respectively. In addition, CRP demonstrated predictive ability of initial antibiotics against infection at 24, 48, and 72 h after therapy, with the AUC of 0.724, 0.741, and 0.797, respectively. ROC curve analysis of percentage changes demonstrated that IL‐6 percentage change showed predictive ability of antibiotic efficacy at the early stage, and both the IL‐6 and CRP percentage changes showed the predictive ability of antibiotic efficacy 48 or 72 h after antibiotics therapy.
Conclusion
This study confirmed IL‐6 and CRP levels, and the percentage change in IL‐6 as the biomarkers for initial antibiotic efficacy prediction in hematological disorder patients with FN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Central Hospital of Xiangtan, Xiangtan, China.
- Department of Hematology, Changsha Central Hospital, Changsha, China.
ORCID-Profile: Zimian Luo
Förderung
- medical research project plan of Xiangtan City in 2021
Zitieren
APA
Zheng, H., Luo, Z., Yi, Y., Liu, K., Huo, Z., You, Y., Li, H., & Tang, M. (2024). Assessment value of interleukin‐6, procalcitonin, and C‐reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: A prospective study. Cancer Medicine. https://doi.org/10.1002/cam4.7307
Vancouver
Zheng H, Luo Z, Yi Y, Liu K, Huo Z, You Y, et al. Assessment value of interleukin‐6, procalcitonin, and C‐reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: A prospective study. Cancer Medicine. 2024. doi:10.1002/cam4.7307
BibTeX
@article{Zheng2024,
author = {Zheng, Haifeng and Luo, Zimian and Yi, Yafei and Liu, Kang and Huo, Zhongjun and You, Yaqin and Li, Hujiao and Tang, Min},
title = {Assessment value of interleukin‐6, procalcitonin, and C‐reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: A prospective study},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.7307}
}
EUVIMED